
Opinion|Videos|August 6, 2024
Therapies Beyond BCG: FDA-Approved and Emerging Options
Experts discuss available therapies beyond BCG.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- For patients who are either unable to receive BCG therapy, or BCG unresponsive, what other therapeutic options are currently available?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
FDA approves cefepime and zidebactam for complicated UTI
3
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
4
Enzalutamide associated with greater cognitive decline than darolutamide in advanced prostate cancer
5












